Search All UT System Experts

An innovative phase ii trial to establish proof of efficacy and optimal dose of a new inhaled epithelial sodium channel inhibitor bi 1265162 in adults and adolescents with cystic fibrosis: Balance-cftm 1

Christopher H. Goss, Raksha Jain, Wolfgang Seibold, Anne Caroline Picard, Ming Chi Hsu, Abhya Gupta, Isabelle Fajac

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Fingerprint

Dive into the research topics of 'An innovative phase ii trial to establish proof of efficacy and optimal dose of a new inhaled epithelial sodium channel inhibitor bi 1265162 in adults and adolescents with cystic fibrosis: Balance-cftm 1'. Together they form a unique fingerprint.

Medicine & Life Sciences